Picture of RLS Global AB logo

RLS RLS Global AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-28.86%
3m-55.84%
6m-73.89%
1yr-87.32%
Volume Change (%)
10d/3m-52.29%
Price vs... (%)
52w High-87.22%
50d MA-21.04%
200d MA-67.43%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-172.34%
Return on Equity-225.95%
Operating Margin-3561.07%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of RLS Global AB EPS forecast chart

Profile Summary

RLS Global AB, formerly OraSolv Products AB, is a Sweden-based company engaged in the development of dental care products. It is primarily engaged in the development of biochemical products and methods for minimally invasive dentistry. The Company’s product portfolio includes Carisolv, a biochemical method for the removal of caries; Perisolv, product for the treatment of periodontitis; ChloraSolv, a treatment that cleanses and heals chronic wounds and Kindersolv, a caries treatment for children. The Company manufactures its products in the Sahlgrenska Science Park and sells them through distributors worldwide. The Company’s main shareholders are Rls Global Intressenter AB, Joki Invest AB, Zebra Holdings and Investments Limited.

Directors

Last Annual
December 31st, 2022
Last Interim
June 30th, 2023
Incorporated
March 15th, 2007
Public Since
May 4th, 2012
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
se flag iconOMX Nordic Exchange Stockholm
Shares in Issue
79,874,705
Blurred out image of a map
Address
Neongatan 5 1Tr, MOELNDAL, 431 53
Web
https://rls.global/
Phone
+46 31531806
Auditors
Ohrlings PricewaterhouseCoopers AB

RLS Share Price Performance

Upcoming Events for RLS

Similar to RLS

Picture of Biogaia AB logo

Biogaia AB

se flag iconOMX Nordic Exchange Stockholm

Picture of BoneSupport Holding AB logo

BoneSupport Holding AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Calliditas Therapeutics AB logo

Calliditas Therapeutics AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Camurus AB logo

Camurus AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Cline Scientific AB logo

Cline Scientific AB

se flag iconOMX Nordic Exchange Stockholm

FAQ

0